Description: The peptide is used to block Anti-CDK11B Antibody (#CPA4966) reactivity. Form: Lyophilized powder Gene Symbol: CDK11B Alternative Names: CDC2L1; CDK11; PITSLREA; PK58; Cyclin-dependent kinase 11B; Cell division cycle 2-like protein kinase 1; CLK-1; Cell division protein kinase 11B; Galactosyltransferase-associated protein kinase p58/GTA; PITSLRE serine/threonine-protein kinase CDC2L1; p58 CLK-1Entrez Gene (Human): 984Entrez Gene (Mouse) : 12537SwissProt (Human): P21127SwissProt (Mouse) : P24788SwissProt (Rat) : P46892Purity : >85%Directions for Use : Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4°C for overnight or at room temperature for 2 hours.Quality Control : The quality of the peptide was evaluated by reversed-phase HPLC and by mass spectrometry.Storage/Stability : Shipped at 4°C. Store at -20°C for one year.

• 
  Western blot analysis of CDK11B expression in HepG2 (A), Hela (B) whole cell lysates.
• 
  Immunohistochemical analysis of CDK11B staining in human breast cancer formalin fixed paraffin embedded tissue section. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0). The section was then incubated with the antibody at room temperature and detected using an HRP conjugacompact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.